Sabra Health Care REIT, Inc. (SBRA)

Over the past six months, several events have impacted Sabra Health Care REIT, Inc.'s stock. In September 2025, Moody's upgraded Sabra's senior unsecured notes to Baa3. The company announced its Q3 2025 earnings release date and conference call on October 22, 2025, and subsequently reported its Q3 2025 results and updated 2025 guidance on November 5, 2025. In November 2025, Sabra declared a quarterly dividend of $0.30 per share. However, consensus EPS estimates for the company fell by 12% on November 19, 2025. Towards the end of 2025, Sabra was mentioned in financial news. In early January 2026, Sabra announced the appointment of Darrin Smith as Chief Investment Officer and the retirement of Talya Nevo-Hacohen. While the stock price increased by 10.92% from January 3, 2025, to January 2, 2026, Sabra underperformed both the US Health Care REITs industry and the broader US market over the past year. Earlier in 2025, the company's Q1 and Q2 earnings calls demonstrated positive momentum and year-over-year growth, with full-year guidance reaffirmed.

Demand for Sabra Health Care REIT, Inc.'s products and services, particularly in senior housing, is significantly influenced by the aging U.S. population. The demand for senior housing currently outpaces supply, contributing to increased occupancy and rents, and boosting long-term cash flow for Sabra. This trend is expected to continue, with projections indicating a need for over 200,000 additional senior housing units by 2028 to accommodate rising demand. Sabra's managed senior housing portfolio demonstrated resilience in Q1 2025, with revenue, cash net operating income (NOI), and margins remaining flat sequentially. Historical data on SBRA's stock implied volatility shows a tendency to rise most in December and decline to its lowest levels in September.

Sabra Health Care REIT, Inc. is a self-administered and self-managed real estate investment trust (REIT) that primarily acquires, finances, and owns real estate properties within the healthcare industry. The company operates within the Real Estate sector and the Healthcare Facilities REIT industry. Sabra's investment portfolio is diversified across various healthcare properties, including skilled nursing/transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Additionally, the company holds investments in loans receivable and preferred equity investments. Sabra leases its properties to third-party operators and tenants, often under triple-net lease agreements.

Sabra Health Care REIT, Inc. has a geographic footprint that spans across the United States and Canada. As of September 30, 2025, its real estate properties held for investment comprised 36,998 beds/units in these two countries. The company's strategic approach emphasizes diversification across various geographic regions, with a notable presence in warm-weather growth markets such as Florida, Texas, and Arizona.

In the past year, Sabra Health Care REIT, Inc. has seen positive developments regarding its brand reputation. In September 2025, Moody's upgraded the company's senior unsecured notes to Baa3. Sabra also published its Fifth Annual Sustainability Report in July 2025, highlighting its commitment to integrating sustainability into its business strategy. The report showcased initiatives such as piloting over 20 healthtech and proptech solutions, investing over $70 million since 2022 to modernize senior housing communities, and achieving an 11.3% reduction in Scope 1 and 2 greenhouse gas emissions intensity from 2022. The report also emphasized a "people-first culture," with 98% of employees recommending Sabra as a great place to work. In June 2024, CEO Rick Matros expressed excitement about the company's recovery from the pandemic and its goal of returning to growth as a "regular REIT." Analyst ratings as of August 2025 included "Somewhat Bullish" and "Indifferent" perspectives. Sabra's core mission is to achieve superior financial returns for shareholders while simultaneously supporting high-quality care through its real estate investments.

Sabra Health Care REIT, Inc. is predominantly owned by institutional investors. Institutional ownership accounts for approximately 97.26% as of Q3 2025, 96.79% as of March 31, 2025, and 94.46% according to the latest available data. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc, Principal Financial Group Inc, State Street Corp, Geode Capital Management, Llc, Engineers Gate Manager LP, Nuveen, Llc, Bank Of America Corp /De/, Charles Schwab Investment Management Inc, and Bank Of New York Mellon Corp. Insider ownership stands at 1.22%, leaving a relatively small float for individual retail investors.